Recursion Pharmaceuticals (RXRX) Gross Margin (2021 - 2026)
Recursion Pharmaceuticals posted quarterly Gross Margin of 92.99% for Q1 2026, down 4494.0% year-on-year from 2.12% in Q1 2025, and down 255.41% on a QoQ basis from 59.83% in Q4 2025.
Recursion Pharmaceuticals (RXRX) has 6 years of Gross Margin data on file, last reported at 92.99% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 4494.0% year-over-year to 92.99%; the trailing twelve-month figure through Mar 2026 stood at 7.22% (up 72.0% YoY), and the FY2025 full-year result was 4.99%, down 1812.0% from the prior year.
- Gross Margin for Q1 2026 stood at 92.99%, down from 59.83% in the prior quarter.
- Across five years, Gross Margin topped out at 59.83% in Q4 2025 and bottomed at 183.81% in Q3 2025.
- The 5-year median for Gross Margin is 3.27% (2023), against an average of 26.59%.
- Peak annual rise in Gross Margin reached 24127 bps in 2025, while the deepest fall reached 23750 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 20.74% in 2022, then plunged by 55 bps to 9.27% in 2023, then plunged by 2056 bps to 181.43% in 2024, then surged by 133 bps to 59.83% in 2025, then slumped by 255 bps to 92.99% in 2026.
- The last three Gross Margin figures came in at 92.99% (Q1 2026), 59.83% (Q4 2025), and 183.81% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 82.22% |
| 10 | Recursion Pharmaceuticals | 1.90 Bn | 1.24 Bn | -6.02 Mn | -92.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.99% |
| Dec 31, 2025 | 59.83% |
| Sep 30, 2025 | -183.81% |
| Jun 30, 2025 | -4.88% |
| Mar 31, 2025 | -48.04% |
| Dec 31, 2024 | -181.43% |
| Sep 30, 2024 | 53.69% |
| Jun 30, 2024 | 36.19% |
| Mar 31, 2024 | 19.05% |
| Dec 31, 2023 | 9.27% |
| Sep 30, 2023 | -3.27% |
| Jun 30, 2023 | 14.84% |
| Mar 31, 2023 | -2.59% |
| Dec 31, 2022 | 20.74% |
| Sep 30, 2022 | -17.09% |
| Jun 30, 2022 | -85.39% |
| Mar 31, 2022 | -46.24% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | 100.00% |